Rigel Pharmaceuticals
RIGL
#6655
Rank
โ‚น69.94 B
Marketcap
โ‚น3,715
Share price
-2.67%
Change (1 day)
-10.29%
Change (1 year)

EPS for Rigel Pharmaceuticals (RIGL)

EPS in 2026 (TTM): โ‚น1,591

According to Rigel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น1,637. In 2025 the company made an earnings per share (EPS) of โ‚น1,875 an increase over its 2024 EPS that were of โ‚น91.73.

EPS history for Rigel Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น1,591-15.15%
2025โ‚น1,8751944.44%
2024โ‚น91.73
2022-โ‚น315.04240%
2021-โ‚น92.66-37.5%
2020-โ‚น148.26-60%
2019-โ‚น370.64-11.11%
2018-โ‚น416.97-26.23%
2017-โ‚น565.23-17.57%
2016-โ‚น685.6825.42%
2015-โ‚น546.69-42.72%
2014-โ‚น954.40
2012-โ‚น1,232

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
โ‚น1,610-1.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น659.74-59.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-โ‚น35.21-102.15%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
-โ‚น175.13-110.70%๐Ÿ‡บ๐Ÿ‡ธ USA